Quantitative and qualitative effect of gH625 on the nanoliposome-mediated delivery of mitoxantrone anticancer drug to HeLa cells

International Journal of Pharmaceutics

Volumn 488, Issue 1-2, 2015, Pages 59-66

  Perillo, Emiliana ^a   Allard Vannier, Emilie ^b   Falanga, Annarita ^a   Stiuso, Paola ^a   Vitiello, Maria Teresa ^a   Galdiero, Massimiliano ^a   Galdiero, Stefania ^a   Chourpa, Igor ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITÉ DE TOURS   (France)

Author keywords

Anticancer drug mitoxantrone (MTX); Cell penetrating peptide (CPP); gH625; Nanoliposomes; Polyethylene glycol (PEG)

Indexed keywords

CELL PENETRATING PEPTIDE; CELL PENETRATING PEPTIDE GH625; DOXORUBICIN; DRUG METABOLITE; LIPOSOME; MACROGOL; MITOXANTRONE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; GH625 PEPTIDE, HERPES SIMPLEX VIRUS TYPE I; MACROGOL DERIVATIVE; NANOPARTICLE; PEPTIDE; VIRUS ENVELOPE PROTEIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOPLASM; CYTOTOXICITY; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG RELEASE; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HELA CELL LINE; HUMAN; HUMAN CELL; HYDROPHOBICITY; METABOLITE; MOLECULAR MECHANICS; NANOENCAPSULATION; OXIDATION KINETICS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; CELL SURVIVAL; CHEMISTRY; CONFOCAL MICROSCOPY; FLOW CYTOMETRY;

ANTINEOPLASTIC AGENTS; CELL SURVIVAL; DRUG LIBERATION; FLOW CYTOMETRY; HELA CELLS; HUMANS; LIPOSOMES; MICROSCOPY, CONFOCAL; MITOXANTRONE; NANOPARTICLES; PEPTIDES; POLYETHYLENE GLYCOLS; VIRAL ENVELOPE PROTEINS;

EID: 84928486818     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2015.04.039     Document Type: Article

References (31)

1. S. Aroui, S. Brahim, M. De Waard, J. Breard, and A. Kenani Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231 Cancer Lett. 285 2009 28 38
2. T.P. Carberry, R. Tarallo, A. Falanga, E. Finamore, M. Galdiero, M. Weck, and S. Galdiero Dendrimer functionalization with a membrane-interacting domain of herpes simplex virus type 1: towards intracellular delivery Chemistry 18 2012 13678 13685
3. Y.S. Choi, and A.E. David Cell penetrating peptides and the mechanisms for intracellular entry Curr. Pharm. Biotechnol. 15 2014 192 199
4. J. Cui, C. Li, C. Wang, Y. Li, L. Zhang, and H. Yang Repeated injection of pegylated liposomal antitumour drugs induces the disappearance of the rapid distribution phase J. Pharm. Pharmacol. 60 2008 1651 1657
5. C.M. Dawidczyk, L.M. Russell, and P.C. Searson Nanomedicines for cancer therapy: state-of-the-art and limitations to pre-clinical studies that hinder future developments Front. Chem. 2 2014 69
6. C.J. Dunn, and K.L. Goa Mitoxantrone: a review of its pharmacological properties and use in acute nonlymphoblastic leukaemia Drugs Aging 9 1996 122 147
7. A. Falanga, M. Cantisani, C. Pedone, and S. Galdiero Membrane fusion and fission: enveloped viruses Protein Pept. Lett. 16 2009 751 759
8. A. Falanga, M.T. Vitiello, M. Cantisani, R. Tarallo, D. Guarnieri, E. Mignogna, P. Netti, C. Pedone, M. Galdiero, and S. Galdiero A peptide derived from herpes simplex virus type 1 glycoprotein H: membrane translocation and applications to the delivery of quantum dots Nanomedicine 7 2011 925 934
9. A. Falanga, R. Tarallo, T. Carberry, M. Galdiero, M. Weck, and S. Galdiero Elucidation of the interaction mechanism with liposomes of gH625-peptide functionalized dendrimers PLoS ONE 9 2014 e112128
10. S. Galdiero, A. Falanga, M. Vitiello, H. Browne, C. Pedone, and M. Galdiero Fusogenic domains in herpes simplex virus type 1 glycoprotein H J. Biol. Chem. 280 2005 28632 28643
11. S. Galdiero, A. Falanga, M. Vitiello, M. D'Isanto, M. Cantisani, A. Kampanaraki, E. Benedetti, H. Browne, and M. Galdiero Peptides containing membrane-interacting motifs inhibit herpes simplex virus type 1 infectivity Peptides 29 2008 1461 1471
12. S. Galdiero, M. Vitiello, A. Falanga, M. Cantisani, N. Incoronato, and M. Galdiero Intracellular delivery: exploiting viral membranotropic peptides Curr. Drug Metab. 13 2012 93 104
13. S. Galdiero, A. Falanga, M. Vitiello, P. Grieco, M. Caraglia, G. Morelli, and M. Galdiero Exploitation of viral properties for intracellular delivery J. Pept. Sci. 20 2014 468 478
14. S. Galdiero, A. Falanga, G. Morelli, and M. Galdiero gH625: a milestone in understanding the many roles of membranotropic peptides Biochim. Biophys. Acta 1848 2015 16 25
15. D. Guarnieri, A. Falanga, O. Muscetti, R. Tarallo, S. Fusco, M. Galdiero, S. Galdiero, and P.A. Netti Shuttle-mediated nanoparticle delivery to the blood-brain barrier Small 9 2013 853 862
16. F. Heitz, M.C. Morris, and G. Divita Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics Br. J. Pharmacol. 157 2009 195 206
17. M.J. Hope, M.B. Bally, G. Webb, and P.R. Cullis Production of large unilamellar vesicles by a rapid extrusion procedure: characterization of size distribution, trapped volume and ability to maintain a membrane potential Biochim. Biophys. Acta 812 1985 55 65
18. N. Kroger, L. Damon, A.R. Zander, H. Wandt, G. Derigs, P. Ferrante, T. Demirer, and G. Rosti Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients Bone Marrow Transplant. 32 2003 1153 1157
19. A. Madni, M. Sarfraz, M. Rehman, M. Ahmad, N. Akhtar, S. Ahmad, N. Tahir, S. Ijaz, R. Al-Kassas, and R. Lobenberg Liposomal drug delivery: a versatile platform for challenging clinical applications J. Pharm. Pharm. Sci. 17 2014 401 426
20. R.F. Novak, and E.D. Kharasch Mitoxantrone: propensity for free radical formation and lipid peroxidation-implications for cardiotoxicity Invest. New Drugs 3 1985 95 99
21. F. Said Hassane, B. Frisch, and F. Schuber Targeted liposomes: convenient coupling of ligands to preformed vesicles using click chemistry Bioconjugate Chem. 17 2006 849 854
22. A. Sharma, and U.S. Sharma Liposomes in drug delivery: progress and limitations Int. J. Pharm. 154 1997 123 140
23. S. Sharonov, I. Chourpa, H. Morjani, I. Nabiev, M. Manfait, and A. Feofanov Confocal spectral imaging analysis in studies of the spatial distribution of antitumour drugs within living cancer cells Anal. Chim. Acta 290 1994 40 47
24. Y. Shen, H. Tang, Y. Zhan, E.A. Van Kirk, and W.J. Murdoch Degradable poly(beta-amino ester) nanoparticles for cancer cytoplasmic drug delivery Nanomedicine 5 2009 192 201
25. G. Smaldone, A. Falanga, D. Capasso, D. Guarnieri, S. Correale, M. Galdiero, P.A. Netti, M. Zollo, S. Galdiero, S. Di Gaetano, and E. Pedone gH625 is a viral derived peptide for effective delivery of intrinsically disordered proteins Int. J. Nanomed. 8 2013 2555 2565
26. R. Tarallo, A. Accardo, A. Falanga, D. Guarnieri, G. Vitiello, P. Netti, G. D'Errico, G. Morelli, and S. Galdiero Clickable functionalization of liposomes with the gH625 peptide from Herpes simplex virus type I for intracellular drug delivery Chemistry 17 2011 12659 12668
27. R. Tarallo, T.P. Carberry, A. Falanga, M. Vitiello, S. Galdiero, M. Galdiero, and M. Weck Dendrimers functionalized with membrane-interacting peptides for viral inhibition Int J Nanomedicine 8 2013 521 534
28. P.G. Tardi, N.L. Boman, and P.R. Cullis Liposomal doxorubicin J. Drug Target. 4 1996 129 140
29. S. Valiante, A. Falanga, L. Cigliano, G. Iachetta, R.A. Busiello, V. La Marca, M. Galdiero, A. Lombardi, and S. Galdiero The peptide gH625 enters into neuron and astrocyte cell lines and crosses the blood brain barrier in rats Int J Nanomedicine 10 2015 1885 1898 10.2147/IJN.S77734
30. S. Vibet, K. Maheo, J. Gore, P. Dubois, P. Bougnoux, and I. Chourpa Differential subcellular distribution of mitoxantrone in relation to chemosensitization in two human breast cancer cell lines Drug Metab. Dispos. 35 2007 822 828
31. L.R. Wiseman, and C.M. Spencer Mitoxantrone. A review of its pharmacology and clinical efficacy in the management of hormone-resistant advanced prostate cancer Drugs Aging 10 1997 473 485